|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.920 USD | +1.20% |
|
+4.97% | -25.75% |
| 06-16 | DiaMedica Therapeutics Inc. Receives FDA Feedback on DM199 Preeclampsia Nonclinical Program | CI |
| 06-16 | DiaMedica Therapeutics Receives US FDA Guidance on DM199 Nonclinical Requirements | MT |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +1.20% | +4.97% | 0.00% | -18.93% | -25.75% | +61.92% | +45.93% | -16.76% | +18.20% | 315M | |
| +2.87% | +4.57% | +13.55% | +35.33% | +11.05% | +70.82% | +119.22% | +198.13% | +6,907.04% | 55.19B | |
| +4.00% | +7.14% | +2.49% | +17.52% | +17.86% | +63.67% | +68.77% | -26.83% | - | 45.75B | |
| +1.13% | +0.90% | -0.56% | +3.63% | -3.76% | -11.06% | -14.62% | -61.26% | - | 22.98B | |
| +2.56% | +0.25% | -8.04% | -32.14% | -43.86% | -7.32% | +380.33% | +253.73% | +887.87% | 20.76B | |
| -0.26% | -1.09% | -6.39% | -9.11% | -2.23% | +27.55% | -18.57% | -77.63% | - | 16.26B | |
| +1.16% | +3.86% | -3.95% | 0.00% | -18.33% | +22.36% | -36.42% | -38.64% | +42.96% | 15.42B | |
| -0.99% | -2.87% | +2.65% | +24.32% | +17.45% | +18.70% | +158.95% | +125.49% | +565.12% | 13.05B | |
| +3.30% | +15.38% | +37.22% | +71.09% | +132.98% | +133.24% | +273.89% | +1,265.34% | +430.66% | 12.45B | |
| -5.63% | -5.49% | -13.49% | -6.03% | +0.05% | +21.79% | - | - | - | 12.37B | |
| +1.31% | +2.50% | -0.97% | +14.41% | -12.04% | +81.01% | +110.46% | +401.13% | - | 11.66B | |
| +1.48% | +7.13% | +10.27% | +45.84% | +24.49% | +432.88% | +132.49% | -6.96% | +1,355.11% | 11.52B | |
| +2.18% | +12.45% | +4.33% | +31.70% | +26.33% | +145.93% | +115.66% | +262.39% | +818.42% | 10.7B | |
| +3.42% | +0.35% | -14.68% | -9.10% | -18.93% | -30.46% | +410.07% | +116.16% | +77.25% | 10.67B | |
| -5.25% | -9.84% | -30.88% | -28.24% | -26.59% | -9.15% | +139.39% | +39.41% | - | 10.29B | |
| -0.09% | +0.04% | +20.84% | +27.97% | +22.68% | +62.41% | +193.32% | - | - | 9.75B | |
| -2.55% | -10.46% | -22.61% | -28.38% | -7.29% | +28.37% | +101.36% | -47.36% | - | 7.8B | |
| -1.70% | +1.19% | -0.07% | -23.24% | +264.39% | +161.41% | +156.76% | -47.18% | - | 7.71B | |
| +11.53% | +17.01% | +32.07% | +128.72% | +198.53% | +566.21% | +757.71% | -38.10% | -12.19% | 7.67B | |
| +0.32% | +2.66% | +7.57% | -9.05% | +10.27% | +53.02% | -5.90% | +138.43% | - | 7.43B | |
| Average | +0.97% | +4.47% | +1.47% | +11.82% | +28.37% | +94.67% | +162.57% | +135.53% | +1,109.04% | 15.49B | |
| Weighted average by Cap. | +1.56% | +3.56% | +2.76% | +14.79% | +18.52% | +75.18% | +139.34% | +132.61% | +2,777.56% |
- Stock Market
- Stocks
- DMAC Stock
- Sector DiaMedica Therapeutics Inc.
Select your edition
All financial news and data tailored to specific country editions
